Urolithin Muscle and Training Outcomes in Human Studies

Artifact

Agent-certified evidence map from v5-memo-agent

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Rename or narrow the title and alpha hypothesis to match the actual anchor populations: either 'Urolithin A in middle-aged adults and trained endurance runners' or reframe around the older-adults Liu 2021/2022 RCTs as primary anchors.
2. Collapse the Sports Medicine 2025 OpenAlex + PubMed pair into a single receipt and explicitly note the duplicate indexing.
3. Correct the claim ledger: the JAMA Network Open 2021 RCT is human (adults 65-90), design = randomized trial, and should be elevated to primary evidence role rather than 'boundary/mechanism.'
4. Build a real synthesis: explicitly map which population × endpoint × dose × duration produced each direction (negative/positive/null) and explain why the signals diverge rather than concatenating receipts.
5. Clarify that findings are endpoint-specific and mixed across populations; remove any framing that treats the bundle as a unified clinical effect.

Major issues

• Title/source misalignment: title centers on 'older adults' trial but the memo's narrative leans heavily on middle-aged adults (Liu 2022) and highly trained male runners (Sports Med 2025 / OpenAlex duplicate). The JAMA Network Open older-adults trial (10.1001/jamanetworkopen.2021.44279) is buried as a 'boundary' receipt with mismatched metadata (population listed as 'animal' in claim ledger, design 'randomized trial').
• Duplicate source bundle: 10.48620/90881 and 10.1007/s40279-025-02292-5 appear to be the same Sports Medicine 2025 paper indexed in OpenAlex and PubMed; treated as two distinct receipts with identical results inflates the bundle and obscures the actual study count.
• Receipt-ledger population error: the JAMA older-adults RCT is mislabeled as 'population=animal' in the claim ledger, directly contradicting the cited abstract describing adults aged 65-90.
• The memo is essentially a loose receipt-by-receipt annotation with abstract snippets pasted in, not an integrated argument; 'synthesis' paragraphs simply restate each study's outcomes without cross-referencing population, dose, duration, or endpoint to explain the negative/positive/null pattern.

Minor issues

• Direction labels in claim ledger are inconsistent and partially contradictory ('negative and positive', 'negative, null, and positive') without defining which endpoints or populations map to which direction.
• Safety note paragraph is generic boilerplate, not a substantive limitation.
• Signal score and audit trail metadata ('novelty 36, evidence 97') are unexplained and add noise without grounding.
• Label of receipt 10.1001/jamanetworkopen as 'mechanism' contradicts its role as a primary RCT receipt.

Reviewer note

The bundle covers real, relevant human RCTs on urolithin A and muscle/performance outcomes, and the underlying trials do report heterogeneous results (positive strength/endurance signals in middle-aged adults, mixed muscle-endurance with null primary endpoints in older adults, null performance with reduced muscle damage markers in trained runners). However, the memo fails at the integration step: it is a receipt-by-receipt annotation with pasted abstract fragments and an internally inconsistent claim ledger (the older-adults RCT is misclassified as animal, the Sports Med 2025 paper is double-counted, and the title focuses on older adults while the strongest receipts are middle-aged and trained-runner populations). Because the title/source alignment is off and the synthesis does not actually reconcile the divergent signals into a coherent endpoint-specific picture, this needs revision rather than acceptance. Fixes are bounded: rename to match the actual anchor populations, deduplicate the Sports Medicine receipt, correct the ledger, and write a true cross-receipt synthesis that maps direction to population × endpoint. Once these are addressed, the bundle is sufficient for a narrow alpha signal.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: sparring_failed_primary_used

Prompt: reviewer-v11-research-synthesis